hpv-vaccination

Documents about hpv-vaccination

• Parental perspectives on human papillomavirus (HPV) vaccination of school-aged girls in Ilishan, Nigeria: A qualitative study protocol#1053213Europe PMC
• Post-vaccination HPV prevalence, genotype distribution, and associated factors among vaccinated women in China: A cross-sectional study.#358772PubMed
• Reaching out-of-school girls with HPV vaccination: A qualitative evaluation in six low- and middle-income countries using the RE-AIM framework#361594bioRxiv / medRxiv
• Factors influencing HPV vaccination intention and uptake behaviors among medical students based on the health belief model and vaccine hesitancy theory: a cross-sectional study.#399614NCBI PubMed Central
• GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose#834972ClinicalTrials.gov
• Effects of a Message-Framing Video Intervention on Maternal Vaccine Confidence Regarding HPV Vaccination for Daughters: A Quasi-Experimental Study Among Mothers With Cervical Intraepithelial Neoplasia.#645528NCBI PubMed Central
• Human papillomavirus vaccine uptake among adolescent girls living with HIV in Côte d’Ivoire: A national cross-sectional survey#137491HAL (France)
• Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer#471509ClinicalTrials.gov
• “Have You Been Vaccinated For Hpv?” - Piloting A Novel Brief Educational Intervention In Otolaryngology Clinics To Improve Patient Knowledge Of Oropharyngeal Cancer And Promote Human Papilloma Virus Vaccination#167472EliScholar
• Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study#272416ClinicalTrials.gov
• The population impact of human papillomavirus vaccination on cancer and pre-cancer outcomes: An umbrella review of meta-analyses#642292Europe PMC
• HPV vaccination in the WHO South-East Asia Region: A scoping review of uptake, implementation challenges, and pathways to acceleration.#412890PubMed
• Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck Cancer#405201ClinicalTrials.gov
• Vaccination coverage against three viral sexually transmitted diseases, among 18-to-30-year-olds seen between May 2023 and May 2024 in the Martinique University Hospital CeGIDD#137444HAL (France)
• HPV vaccine awareness and uptake among women attending cervical screening in health-resource-limited areas of China: A multicenter cross-sectional study#5101Europe PMC
• Near-peer education by medical students and its association with HPV vaccination knowledge and attitudes among Japanese adolescents: An exploratory intervention study#635040Figshare
• One-year impact on HPV vaccination coverage of a school- and primary care-based intervention: the PrevHPV cluster randomised trial#311946HAL (France)
• HPV Vaccination among Sexual and Gender Minority Youth Living with or at High-Risk for HIV#922192eScholarship